Testosterone Recovery and Associated Impact on Patient-Reported Health-Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial
| Autor: | Moningi, S., Nguyen, P.L., Rathkopf, D., Zurita-Saavedra, A., Spratt, D.E., Dess, R.T., Liauw, S., Szmulewitz, R., Einstein, D.J., Bubley, G., Yu, J.B., An, Y., Wong, A.C., Feng, F.Y., Mckay, R.R., Rose, B.S., Shin, K.Y., Taplin, M.E.A., Kollmeier, M.A., Hoffman, K.E. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:e563-e564 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|